Evidence map›Paper›PMID 31235651›Full record

ArticleMedical humanities2020

Psychedelic crossings: American mental health and LSD in the 1970s.

Lucas Richert, Erika Dyck

Open access · hybridAbstract readHistorical Article
In one paragraph

Article in Medical humanities, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. A history and future of psychedelics: The case of the Canadian military.Journal of military, veteran and family health · 2023
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Lucas RichertSchool of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA lucas.richert@wisc.edu Erika.Dyck@usask.ca.ORCID http://orcid.org/0000-0002-5593-4383
Erika DyckDepartment of History, University of Saskatchewan, Saskatoon, Saskatchewan, Canada lucas.richert@wisc.edu Erika.Dyck@usask.ca.
University of Saskatchewan · CAUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article places a spotlight on lysergic acid diethylamide (LSD) and American mental health in the 1970s, an era in which psychedelic science was far from settled and researchers continued to push the limits of regulation, resist change and attempt to revolutionise the mental health market-place. The following pages reveal some of the connections between mental health, LSD and the wider setting, avoiding both ascension and declension narratives. We offer a renewed approach to a substance, LSD, which bridged the gap between biomedical understandings of 'health' and 'cure' and the subjective needs of the individual. Garnering much attention, much like today, LSD created a cross-over point that brought together the humanities and arts, social sciences, health policy, medical education, patient experience and the public at large. It also divided opinion. This study draws on archival materials, medical literature and popular culture to understand the dynamics of psychedelic crossings as a means of engendering a fresh approach to cultural and countercultural-based healthcare during the 1970s.

Indexed as

HallucinogensHistory, 20th CenturyHumanitiesHumansLysergic Acid DiethylamideMental HealthUnited StatesHallucinogensLysergic Acid DiethylamidecultureLSDmental healthpsychiatrypsychology

Identifiers

PMID31235651
PMCPMC7476284
OpenAlexW2951531792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.